Search results

Found 134 releases mentioning: takeda pharmaceutical

Business Wire Australia and New Zealand

Takeda Announces Publication of Circular and Notice of Extraordinary General Meeting of Shareholders in Relation to the Proposed Acquisition of Shire

12 Nov 2018

Business Wire Australia and New Zealand

Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment Needs for Blood Cancers

02 Nov 2018

Business Wire Australia and New Zealand

Takeda Reports Second Quarter FY2018 Results

31 Oct 2018

Business Wire Australia and New Zealand

Takeda Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc

28 Oct 2018

Business Wire Australia and New Zealand

Takeda Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc

26 Oct 2018

Business Wire Australia and New Zealand

Takeda to Highlight Data in Hodgkin Lymphoma During the 11th International Symposium on Hodgkin Lymphoma

26 Oct 2018

Business Wire Australia and New Zealand

Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

22 Oct 2018

Business Wire Australia and New Zealand

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer

21 Oct 2018

Business Wire Australia and New Zealand

Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc

18 Oct 2018

Business Wire Australia and New Zealand

Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health

17 Oct 2018

Business Wire Australia and New Zealand

Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline CD30-Expressing Peripheral T-Cell Lymphoma

02 Oct 2018

Business Wire Australia and New Zealand

Takeda Establishes Record Date for the Extraordinary General Meeting of Shareholders

28 Sep 2018

Display

Sort by

Your saved searches

If you regularly search for a topic or keyword, you can save the current search criteria for quick access in future. Saved searches will be listed here.

Refine results